Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–20.

Article  CAS  PubMed  Google Scholar 

Global burden of. 288 Causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the global burden of disease study 2021. Lancet. 2024;403(10440):2100–32.

Article  Google Scholar 

Wool GD, Miller JL. The impact of COVID-19 disease on platelets and coagulation. Pathobiology. 2021;88(1):15–27.

Article  CAS  PubMed  Google Scholar 

Sarkar M, Madabhavi IV, Quy PN, Govindagoudar MB. COVID-19 and coagulopathy. Clin Respir J. 2021;15(12):1259–74.

Article  CAS  PubMed  Google Scholar 

Dybowska M, Wyrostkiewicz D, Opoka L, Lewandowska K, Sobiecka M, Tomkowski W et al. Venous thromboembolic disease in COVID-19, pathophysiology, therapy and prophylaxis. Int J Mol Sci. 2022;23(18).

Trimaille A, Bonnet G. [COVID-19 and venous thromboembolism]. Ann Cardiol Angeiol (Paris). 2020;69(6):370–5.

Article  CAS  PubMed  Google Scholar 

Bertoletti L, Couturaud F, Montani D, Parent F, Sanchez O. Venous thromboembolism and COVID-19. Respir Med Res. 2020;78:100759.

CAS  PubMed  PubMed Central  Google Scholar 

Zuin M, Rigatelli G, Bilato C, Quadretti L, Roncon L, Zuliani G. COVID-19 patients with acute pulmonary embolism have a higher mortality risk: systematic review and meta-analysis based on Italian cohorts. J Cardiovasc Med (Hagerstown). 2022;23(12):773–8.

Article  PubMed  Google Scholar 

Deitelzweig S, Luo X, Nguyen JL, Malhotra D, Emir B, Russ C, et al. Thrombotic and bleeding events, mortality, and anticoagulant use among 546,656 hospitalized patients with COVID-19 in the united States: a retrospective cohort study. J Thromb Thrombolysis. 2022;53(4):766–76.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Farkouh ME, Stone GW, Lala A, Bagiella E, Moreno PR, Nadkarni GN, et al. Anticoagulation in patients with COVID-19: JACC review topic of the week. J Am Coll Cardiol. 2022;79(9):917–28.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fanaroff AC, Lopes RD. COVID-19 thrombotic complications and therapeutic strategies. Annu Rev Med. 2023;74:15–30.

Article  CAS  PubMed  Google Scholar 

Schulman S, Sholzberg M, Spyropoulos AC, Zarychanski R, Resnick HE, Bradbury CA, et al. ISTH guidelines for antithrombotic treatment in COVID-19. J Thromb Haemost. 2022;20(10):2214–25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Siegal DM, Tseng EK, Schünemann HJ, Angchaisuksiri P, Cuker A, Dane K, et al. American society of hematology living guidelines on use of anticoagulation for thromboprophylaxis for patients with COVID-19: executive summary. Blood Adv. 2025;9(6):1247–60.

Article  CAS  PubMed  Google Scholar 

Bikdeli B, Talasaz AH, Rashidi F, Bakhshandeh H, Rafiee F, Rezaeifar P, et al. Intermediate-Dose versus Standard-Dose prophylactic anticoagulation in patients with COVID-19 admitted to the intensive care unit: 90-Day results from the INSPIRATION randomized trial. Thromb Haemost. 2022;122(1):131–41.

Article  PubMed  Google Scholar 

Zhai Z, Kan Q, Li W, Qin X, Qu J, Shi Y, et al. VTE risk profiles and prophylaxis in medical and surgical inpatients: the identification of Chinese hospitalized patients’ risk profile for venous thromboembolism (DissolVE-2)-A Cross-sectional study. Chest. 2019;155(1):114–22.

Article  PubMed  Google Scholar 

Moores LK, Tritschler T, Brosnahan S, Carrier M, Collen JF, Doerschug K, et al. Thromboprophylaxis in patients with COVID-19: A brief update to the CHEST guideline and expert panel report. Chest. 2022;162(1):213–25.

Article  CAS  PubMed  Google Scholar 

Kyriakoulis KG, Dimakakos E, Kyriakoulis IG, Catalano M, Spyropoulos AC, Schulman S et al. Practical recommendations for optimal thromboprophylaxis in patients with COVID-19: A consensus statement based on available clinical trials. J Clin Med. 2022;11(20).

Diagnosis. Treatment protocol for COVID-19 patients (Tentative 10th Version). Health Care Sci. 2023;2(1):10–24.

Article  Google Scholar 

Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005;3(4):692–4.

Article  CAS  PubMed  Google Scholar 

Kaatz S, Ahmad D, Spyropoulos AC, Schulman S. Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH. J Thromb Haemost. 2015;13(11):2119–26.

Article  CAS  PubMed  Google Scholar 

Kim HK, Tantry US, Smith SC Jr., Jeong MH, Park SJ, Kim MH, et al. The East Asian paradox: an updated position statement on the challenges to the current antithrombotic strategy in patients with cardiovascular disease. Thromb Haemost. 2021;121(4):422–32.

Article  PubMed  Google Scholar 

Patel AP, Wang M, Pirruccello JP, Ellinor PT, Ng K, Kathiresan S, et al. Lp(a) (Lipoprotein[a]) concentrations and incident atherosclerotic cardiovascular disease: new insights from a large National biobank. Arterioscler Thromb Vasc Biol. 2021;41(1):465–74.

Article  CAS  PubMed  Google Scholar 

Jeong YH, Kevin B, Ahn JH, Chaudhary R, Kang MG, Park HW, et al. Viscoelastic properties of clot formation and their clinical impact in East Asian versus Caucasian patients with stable coronary artery disease: a COMPARE-RACE analysis. J Thromb Thrombolysis. 2021;51(2):454–65.

Article  CAS  PubMed  Google Scholar 

Albert MA, Glynn RJ, Buring J, Ridker PM. C-reactive protein levels among women of various ethnic groups living in the united States (from the women’s health Study). Am J Cardiol. 2004;93(10):1238–42.

Article  CAS  PubMed  Google Scholar 

Hayashi H, Izumiya Y, Fukuda D, Wakita F, Mizobata Y, Fujii H, et al. Real-World management of Pharmacological thromboprophylactic strategies for COVID-19 patients in Japan: from the CLOT-COVID study. JACC Asia. 2022;2(7):897–907.

Article  PubMed  PubMed Central  Google Scholar 

Voigtlaender M, Edler C, Gerling M, Schädler J, Ondruschka B, Schröder AS, et al. Thromboembolic events in deceased patients with proven SARS-CoV-2 infection: frequency, characteristics and risk factors. Thromb Res. 2022;218:171–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lobbes H, Mainbourg S, Mai V, Douplat M, Provencher S, Lega JC. Risk factors for venous thromboembolism in severe COVID-19: A Study-Level Meta-Analysis of 21 studies. Int J Environ Res Public Health. 2021;18(24).

Decousus H, Tapson VF, Bergmann JF, Chong BH, Froehlich JB, Kakkar AK, et al. Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators. Chest. 2011;139(1):69–79.

Article  PubMed  Google Scholar 

Sadeghipour P, Talasaz AH, Rashidi F, Sharif-Kashani B, Beigmohammadi MT, Farrokhpour M, et al. Effect of Intermediate-Dose vs Standard-Dose prophylactic anticoagulation on thrombotic events, extracorporeal membrane oxygenation treatment, or mortality among patients with COVID-19 admitted to the intensive care unit: the INSPIRATION randomized clinical trial. JAMA. 2021;325(16):1620–30.

Article  CAS  PubMed  Google Scholar 

Goligher EC, Bradbury CA, McVerry BJ, Lawler PR, Berger JS, Gong MN, et al. Therapeutic anticoagulation with heparin in critically ill patients with Covid-19. N Engl J Med. 2021;385(9):777–89.

Article  PubMed  Google Scholar 

Bohula EA, Berg DD, Lopes MS, Connors JM, Babar I, Barnett CF, et al. Anticoagulation and antiplatelet therapy for prevention of venous and arterial thrombotic events in critically ill patients with COVID-19: COVID-PACT. Circulation. 2022;146(18):1344–56.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wichmann D, Sperhake JP, Lütgehetmann M, Steurer S, Edler C, Heinemann A, et al. Autopsy findings and venous thromboembolism in patients with COVID-19: A prospective cohort study. Ann Intern Med. 2020;173(4):268–77.

Article  PubMed  Google Scholar 

Uaprasert N, Tangcheewinsirikul N, Rojnuckarin P, Patell R, Zwicker JI, Chiasakul T. Heparin-induced thrombocytopenia in patients with COVID-19: a systematic review and meta-analysis. Blood Adv. 2021;5(21):4521–34.

Article  CAS